caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1619951175

Howard HueyD.O.

EndocrinologyNew York, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
267
Unique beneficiaries
—
Total services
477
Distinct HCPCS
4
Medicare payment
$27K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 627 Endocrinology providers in NY — below median (cohort median 837).
REFERRAL NETWORK

Where Howard Huey's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
111376
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
2865
Jian Liang
Podiatry · New York, NY
2238
Kenneth Tam
Internal Medicine · New York, NY
1965
Calvin Lo
Diagnostic Radiology · New York, NY
1622
BETH ISRAEL MEDICAL CENTER1234
Richard Chan
Nephrology · New York, NY
1136
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
5,314
Beneficiaries
—
Total drug cost
$1.7M
Distinct drugs
63
Brand share
53.0%
Top prescribed drugs
Metformin Hcl568 claims
Levothyroxine Sodium449 claims
Semaglutide390 claims
Glimepiride295 claims
Atorvastatin Calcium240 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.